Steris Plc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 47.85
Dividend & Yield1.88$ (1.00%)
Beta 0.83
Market capitalization 18.86B
Operating cash flow 712.88M
ESG Scores unknown

Company description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio1.55
Working Capital0.63
Return On Equity0.1
Debt To Equity0.43
Fixed Asset Ratio0.15
Fixed Interest Cover16.32

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 21.24M -2.78M -7.21M 14.89M
Total Cashflows From Investing Activities -213.22M -319.74M -1.15B -666.56M
Net Borrowings -112.09M -26.5M 484.54M 372.18M
Total Cash From Financing Activities -294.79M -163.15M 345.62M 115.83M
Change To Operating Activities 51.76M 9.97M 10.37M -9.27M
Issuance Of Stock 13.36M 34.73M 26.73M 10.07M
Net Income 303.72M 407.66M 397.4M 243.89M
Change In Cash 19.1M 98.95M -99.05M 127.79M
Effect Of Exchange Rate -12.39M -8.73M 19.85M -6.29M
Total Cash From Operating Activities 539.5M 590.56M 689.64M 684.81M
Depreciation 225.92M 197.24M 219.24M 553.1M
Change To Account Receivables -48.49M -17.87M 12.08M -51.97M
Other Cashflows From Financing Activities -2.07M 2.9M -17.16M -47.48M
Change To Netincome -475k 35.48M 54M 37.09M
Capital Expenditures -189.72M -214.52M -239.26M -287.56M

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development 63.04M 65.55M 66.33M 87.94M
Income Before Tax 369.03M 498.75M 517.53M 314.5M
Net Income 303.72M 407.66M 397.4M 243.89M
Selling General Administrative 644.79M 708.51M 695.69M 1.3B
Gross Profit 1.17B 1.32B 1.34B 2.02B
Ebit 467.16M 545.94M 581.09M 631.45M
Operating Income 467.16M 545.94M 581.09M 631.45M
Interest Expense -45.02M -40.28M -37.18M -89.59M
Income Tax Expense 64.28M 90.89M 120.66M 71.63M
Total Revenue 2.78B 3.03B 3.11B 4.59B
Cost Of Revenue 1.61B 1.71B 1.76B 2.57B
Total Other Income ExpenseNet -98.13M -47.19M -63.55M -316.95M
Net Income From Continuing Ops 304.75M 407.86M 396.87M 242.87M
Net Income Applicable To Common Shares 303.72M 407.66M 397.4M 243.89M

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 1.89B 2.02B 2.68B 4.88B
Total Stockholder Equity 3.18B 3.41B 3.88B 6.53B
Other Current Liabilities 139.3M 135.52M 165.96M 241.36M
Total Assets 5.07B 5.44B 6.57B 11.42B
Common Stock 2B 1.98B 2B 4.74B
Other Current Assets 552k 124k 57k 2.78M
Retained Earnings 1.34B 1.66B 1.94B 2B
Treasury Stock -159.78M -235.46M -61.24M -209.81M
Cash 220.63M 319.58M 220.53M 348.32M
Total Current Liabilities 465.2M 503.61M 577.92M 922.22M
Other Stockholder Equity -159.78M -235.46M -61.24M -209.81M
Property, Plant, and Equipment 1.03B 1.24B 1.39B 1.74B
Total Current Assets 1.05B 1.22B 1.21B 1.88B
Net Tangible Assets 250.27M 483.8M -43.47M -1.2B
Net Receivables 564.83M 586.48M 609.41M 799.04M
Accounts Payable 152.91M 149.34M 156.95M 225.74M


Insider Transactions

Here are the insider transactions of stock shares related to Steris Plc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
BREEDEN RICHARD C.Conversion of Exercise of derivative security at price 43.92 per share.D2023-02-15Director4.66k
XILAS ANDREWD2022-12-02Officer333
MAJORS CARY LSale at price 192.51 per share.D2022-12-01Officer1.6k
XILAS ANDREWD2022-10-10Officer503
XILAS ANDREWD2022-10-07Officer606
ZANGERLE JOHN ADAMSale at price 205.31 per share.D2022-06-15General Counsel2.66k
BREEDEN RICHARD C.Conversion of Exercise of derivative security at price 32.36 per share.D2022-06-02Director3.22k
TOKICH MICHAEL JOSEPHStock Award(Grant) at price 0.00 per share.D2022-06-02Chief Financial Officer2.26k
ZANGERLE JOHN ADAMStock Award(Grant) at price 0.00 per share.D2022-06-02General Counsel3.38k
CARESTIO DANIEL AStock Award(Grant) at price 0.00 per share.D2022-06-02Chief Executive Officer9.48k
BURTON KAREN LStock Award(Grant) at price 0.00 per share.D2022-06-02Officer900
TAMARO RENATOStock Award(Grant) at price 0.00 per share.D2022-06-02Officer and Treasurer564
MAJORS CARY LStock Award(Grant) at price 0.00 per share.D2022-06-02Officer2.14k
FRASER MARY CLAREStock Award(Grant) at price 0.00 per share.D2022-06-02Officer2.03k
MADSEN JULIAStock Award(Grant) at price 0.00 per share.D2022-06-02Officer1.41k
XILAS ANDREWStock Award(Grant) at price 0.00 per share.D2022-06-02Officer1.41k
ZANGERLE JOHN ADAMSale at price 255.48 per share.D2022-04-20General Counsel8k
ZANGERLE JOHN ADAMConversion of Exercise of derivative security at price 67.98 per share.D2022-04-20General Counsel8k
TOKICH MICHAEL JOSEPHSale at price 250.00 per share.D2022-04-07Chief Financial Officer8k
BURTON KAREN LSale at price 246.00 per share.D2022-03-29Officer4k
BURTON KAREN LConversion of Exercise of derivative security at price 77.07 per share.D2022-03-29Officer4k
BURTON KAREN LSale at price 232.61 per share.D2022-02-15Officer2.6k
BURTON KAREN LConversion of Exercise of derivative security at price 69.72 per share.D2022-02-15Officer2.6k
KOSECOFF JACQUELINE BSale at price 235.20 per share.D2022-02-10Director3.22k
KOSECOFF JACQUELINE BConversion of Exercise of derivative security at price 32.36 per share.D2022-02-10Director3.22k
FELDMANN CYNTHIA LSale at price 234.10 per share.D2022-02-10Director1.89k
FELDMANN CYNTHIA LConversion of Exercise of derivative security at price 71.40 per share.D2022-02-10Director1.89k
TOKICH MICHAEL JOSEPHSale at price 240.00 per share.D2021-12-23Chief Financial Officer30k
TOKICH MICHAEL JOSEPHConversion of Exercise of derivative security at price 69.72 per share.D2021-12-23Chief Financial Officer30k
XILAS ANDREWD2021-12-02Officer333
MAJORS CARY LSale at price 232.97 per share.D2021-11-15Officer1.95k
TOKICH MICHAEL JOSEPHSale at price 235.00 per share.D2021-10-22Chief Financial Officer20k
TOKICH MICHAEL JOSEPHConversion of Exercise of derivative security at price 67.98 per share.D2021-10-22Chief Financial Officer20k
XILAS ANDREWD2021-10-11Officer506
XILAS ANDREWD2021-10-07Officer607
TOKICH MICHAEL JOSEPHStock Award(Grant) at price 0.00 per share.D2021-10-01Chief Financial Officer576
ZANGERLE JOHN ADAMStock Award(Grant) at price 0.00 per share.D2021-10-01General Counsel808
CARESTIO DANIEL AStock Award(Grant) at price 0.00 per share.D2021-10-01Chief Operating Officer1.16k
BURTON KAREN LStock Award(Grant) at price 0.00 per share.D2021-10-01Officer344
TAMARO RENATOStock Award(Grant) at price 0.00 per share.D2021-10-01Officer and Treasurer344
MAJORS CARY LStock Award(Grant) at price 0.00 per share.D2021-10-01Officer692
FRASER MARY CLAREStock Award(Grant) at price 0.00 per share.D2021-10-01Officer692
MADSEN JULIAStock Award(Grant) at price 0.00 per share.D2021-10-01Officer576
XILAS ANDREWStock Award(Grant) at price 0.00 per share.D2021-10-01Officer1.16k
TAMARO RENATOSale at price 213.63 per share.D2021-08-26Officer and Treasurer1.45k
TAMARO RENATOConversion of Exercise of derivative security at price 69.72 - 114.22 per share.D2021-08-26Officer and Treasurer1.45k
MAJORS CARY LStock Award(Grant) at price 0.00 per share.D2021-08-13Officer10k
MAJORS CARY LSale at price 218.43 - 218.64 per share.D2021-08-13Officer11k
SHAH NIRAV RStock Award(Grant) at price 0.00 per share.D2021-08-10Director500
LEWIS DAVID BAKERConversion of Exercise of derivative security at price 31.61 per share.D2021-07-21Director1.56k
BREEDEN RICHARD C.Stock Award(Grant) at price 0.00 per share.D2021-06-02Director160

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Steris Plc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Steris Plc

Here is the result of two systematic investment strategies applied to Steris Plc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Steris Plc

The following chart shows the equity curve of the two systematic investment strategies applied to Steris Plc:

Steris Plc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 55.16% on the backtest period.

Performance at glance

Performance

55.16 %

Latent gain

1252.59 $

Invested capital

2270.77 $

Annualized return

13.32 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Steris Plc

This is the result of two momentum investment strategies applied to Steris Plc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Steris Plc

The following chart shows all the entries opened by the momentum investment system on Steris Plc:

Steris Plc momentum entries
  • The first momentum investment strategy would give 70.62% of return on Steris Plc. That represents 4010.44$ of latent gain with 5678.8$ of employed capital.
  • The second momentum investment strategy would give 52.24% of return on Steris Plc. That represents 1889.2$ of latent gain with 3616.05$ of employed capital.
Performance at glance (1Q Momentum)

Performance

70.62 %

Latent gain

4010.44 $

Invested capital

5678.8 $

Annualized return

21.29 %
Performance at glance (2Q Momentum)

Performance

52.24 %

Latent gain

1889.2 $

Invested capital

3616.05 $

Annualized return

14.27 %

Momentum equity curve on Steris Plc

The following chart shows the equity curve of the two momentum strategies applied to Steris Plc:

Steris Plc momentum equity

Note: the dividends potentially given by Steris Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Steris Plc

The following chart shows the employed capital evolution of the two momentum strategies on Steris Plc since the beginning:

Steris Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Steris Plc

Buy the dip entry openings on Steris Plc

Steris Plc

The performance achieved by the robo-advisor on Steris Plc is 45.57%. That represents 344.69$ of latent gain with 756.36$ of employed capital. The following chart shows Steris Plc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Steris Plc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

45.57 %

Latent gain

344.69 $

Invested capital

756.36 $

Annualized return

21.29 %

Equity curve of the strategy applied to Steris Plc

The following chart shows the result of the investment strategy applied to Steris Plc:

Steris Plc

Note: the dividends potentially given by Steris Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Steris Plc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Steris Plc:

Steris Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Steris Plc

In this section, I will compare the three previous investment strategies applied to Steris Plc.

Equity curve comparison on Steris Plc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Steris Plc investment strategy comparison

Employed capital comparison on Steris Plc

Steris Plc investment comparison

Performance comparison on Steris Plc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 55.16% 1252.59$ 2270.77$ 13.32%
Momentum 1 quarter 70.62% 4010.44$ 5678.8$ 18.11%
Momentum 2 quarters 52.24% 1889.2$ 3616.05$ 14.27%
Non-directional 45.57% 344.69$ 756.36$ 21.29%
Annualized return comparison

Automatic investment

13.32 %

Momentum 1Q

14.27 %

Momentum 2Q

14.27 %

Non-directional

21.29 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Steris Plc:

Positive correlations

Most correlated stocks this year

  • Steris Plc

  • Most correlated stocks last 3 months

  • CDN NATURAL RES
  • Permian Basin Royalty Trust
  • YOMA STRATEGIC
  • BUMITAMA AGRI
  • Franklin FTSE South Africa ETF
  • Steris Plc
  • Ecopetrol SA

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • Montrose Environmental Group Inc

  • Note: The algorithm computes the probability of correlation between Steris Plc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Steris Plc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Steris Plc
    Country Ireland
    City Dublin
    Address 70 Sir John Rogerson’s Quay
    Phone 353 1 232 2000
    Website www.steris.com
    FullTime employees 16000
    Industry Medical Devices
    Sector Healthcare
    Exchange XNYS
    Ticker STE
    Market www.nyse.com

    Steris Plc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown